Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Free Radical Biology & Medicine|March 5, 2020
Arginase inhibitor, N<sup>ω</sup>-hydroxy-L-norarginine, spontaneously releases biologically active NO-like molecule: Limitations for research applicationsTony Y Momma, Javier I Ottaviani
Nitric Oxide : Biology and Chemistry|September 20, 2022
There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginineTony Y Momma, Javier I Ottaviani
Food & Function|April 26, 2021
Evolution of cocoa flavanol analytics: impact on reporting and cross-study comparisonUgo Bussy, Javier I Ottaviani, Catherine Kwik-Uribe
Molecular Aspects of Medicine|August 28, 2022
Measuring the intake of dietary bioactives: Pitfalls and how to avoid themJavier I Ottaviani, Hagen Schroeter, Gunter G C Kuhnle
Journal of Agricultural and Food Chemistry|January 5, 2006
Inhibition of angiotensin converting enzyme activity by flavanol-rich foodsLucas Actis-Goretta, Javier I Ottaviani, Cesar G Fraga
The American Journal of Clinical Nutrition|March 2, 2012
Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humansJavier I Ottaviani, Catherine Kwik-Uribe, Carl L Keen, et al.
FEBS Letters|December 17, 2003
Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidinsLucas Actis-Goretta, Javier I Ottaviani, Carl L Keen, et al.
Free Radical Biology & Medicine|June 6, 2018
Use of LC-MS for the quantitative analysis of (poly)phenol metabolites does not necessarily yield accurate results: Implications for assessing existing data and conducting future researchJavier I Ottaviani, Reedmond Y Fong, Gina Borges, et al.
Biochimie|December 7, 2005
Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibitionJavier I Ottaviani, Lucas Actis-Goretta, Juan J Villordo, et al.
Elife|June 19, 2024
Reliance on self-reports and estimated food composition data in nutrition research introduces significant bias that can only be addressed with biomarkersJavier I Ottaviani, Virag Sagi-Kiss, Hagen Schroeter, et al.
Pageof 4